-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation